Gaviscon and Nitrolingual drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gaviscon (aluminum hydroxide; magnesium trisilicate) and Nitrolingual (nitroglycerin). Common drug interactions include abdominal pain among females and mesothelioma among males.

The phase IV clinical study analyzes what interactions people have when they take Gaviscon and Nitrolingual. It is created by eHealthMe based on reports of 55 people who take the same drugs from the FDA, and is updated regularly.

What is Gaviscon?

Gaviscon has active ingredients of aluminum hydroxide; magnesium trisilicate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 12,355 Gaviscon users. Check the latest studies of Gaviscon.

What is Nitrolingual?

Nitrolingual has active ingredients of nitroglycerin. eHealthMe is studying from 2,777 Nitrolingual users. Check the latest studies of Nitrolingual.



On Jul, 28, 2026

55 people who take Gaviscon and Nitrolingual together, and have interactions are studied.

Gaviscon and Nitrolingual drug interactions.

What are the common drug interactions of Gaviscon and Nitrolingual, by gender? *:

female:

  1. Abdominal pain
  2. Sedation
  3. Arthralgia (joint pain)
  4. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  5. Cardiac failure congestive
  6. Chest pain
  7. Confusional state
  8. Depressed level of consciousness
  9. Disturbance in attention
  10. Dry mouth

male:

  1. Mesothelioma (rare type of cancer that occurs in the thin layer of cells lining the body's internal organs, known as the mesothelium)
  2. Lung neoplasm malignant (cancer tumour of lung)
  3. Fall
  4. Pleural mesothelioma (cancer of the pleura, or the membrane that lines the lungs)
  5. Pruritus (severe itching of the skin)
  6. Syncope (loss of consciousness with an inability to maintain postural tone)
  7. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  8. Fluid retention (an abnormal accumulation of fluid in the blood)
  9. Pemphigoid (tense blisters on the skin)
  10. Sudden death

What are the common drug interactions of Gaviscon and Nitrolingual, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Mesothelioma (rare type of cancer that occurs in the thin layer of cells lining the body's internal organs, known as the mesothelium)
  2. Lung neoplasm malignant (cancer tumour of lung)
  3. Arthralgia (joint pain)
  4. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  5. Confusional state
  6. Depressed level of consciousness
  7. Disturbance in attention
  8. Dry mouth
  9. Duodenal ulcer
  10. Dysgeusia (disorder of the sense of taste)

What are the existing conditions these people have? *

  1. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 5 people, 9.09%
  2. Constipation: 4 people, 7.27%
  3. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 7.27%
  4. Pain: 3 people, 5.45%
  5. Malignant Melanoma (skin cancer rises from melancytes): 3 people, 5.45%
  6. High Blood Pressure: 3 people, 5.45%

* Approximation only. Some reports may have incomplete information.

Do you take Gaviscon and Nitrolingual?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Gaviscon and Nitrolingual:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gaviscon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nitrolingual:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gaviscon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nitrolingual and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on aluminum hydroxide; magnesium trisilicate and nitroglycerin (the active ingredients of Gaviscon and Nitrolingual, respectively), and Gaviscon and Nitrolingual (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: